# Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea

> **NCT01129102** · PHASE3 · COMPLETED · sponsor: **Nobelpharma** · enrollment: 215 (actual)

## Conditions studied

- Dysmenorrhea

## Interventions

- **DRUG:** NPC-01
- **DRUG:** IKH-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01129102
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129102, "Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01129102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*